News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Edwards Lifesciences Corporation (EW) Goes After Another Set of Medtronic, Inc. (MDT) Patents


7/17/2013 7:39:58 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Edwards Lifesciences wants a federal judge to invalidate a pair of patents covering nerve stimulation sensing technology owned by arch-rival Medtronic. Edwards Lifesciences (NYSE:EW) wants a federal judge to rule that a pair of patents owned by arch-rival Medtronic (NYSE:MDT) are invalid because they aren't specific enough. The patents – the so-called '741 patent for a "Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure" and the '829 patent for a "Method and system for nerve stimulation prior to and during a medical procedure – cover nerve stimulation technology.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES